Track topics on Twitter Track topics that are important to you
Science Exchange, a secure enterprise platform for outsourced research and development (R&D) services, announced that Elizabeth Iorns, Ph.D., CEO of Science Exchange, has been elected to serve her first term on the Board of Directors of the Drug, Chemical & Associated Technologies Association (DCAT) beginning November 1, 2017. Members of DCAT’s Board of Directors are […]
The post Elizabeth Iorns elected to the Board of Directors DCAT appeared first on CenterWatch News Online.
Original Article: Elizabeth Iorns elected to the Board of Directors DCATNEXT ARTICLE
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...